Allergan, Inc. v. Actavis plc et al > Documents

Date Field	Doc. No.	Description (Pages)
May 23, 2014	1	Civil Cover Sheet (1)
May 23, 2014	2	Exhibit 1 U.S. Patent No. 8,633,162 (12)
May 23, 2014	3	Exhibit 2 U.S. Patent No. 8,642,556 (13)
May 23, 2014	4	Exhibit 3 U.S. Patent No. 8,648,048 (12)
May 23, 2014	5	Exhibit 4 U.S. Patent No. 8,685,930 (12)
May 23, 2014	6	Exhibit 5 redacted copy of the purported April 8th Paragraph IV Notification (48)
May 23, 2014	3	Jury Demand (3)
May 23, 2014	7	Exhibit 6 - Press release (3)
May 23, 2014	8	Exhibit 7 Correspondence from J. Singer to B. Anderson (3)
May 23, 2014	9	Exhibit 8 FDA correspondence (5)
May 23, 2014	10	Exhibit 9 print out from FDAs Paragraph IV Patent Certifications Database (46)
May 23, 2014	5	Notice of Attorney Appearance (2)
May 23, 2014	6	Notice of Attorney Appearance (2)
May 23, 2014	8	Notice of Attorney Appearance (3)
May 23, 2014	9	Notice of Attorney Appearance (3)
May 23, 2014	10	Notice of Attorney Appearance (3)
May 23, 2014	11	Notice of Attorney Appearance (3)
May 23, 2014	2	Corporate Disclosure Statement (3)
May 23, 2014	1	Main Document (32)